Archive

GLP-1 drugs linked to reduced risk of epilepsy

Written by Bruce Sylvester | 14 Dec 2025

A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles in clinical settings

Written by Charlie King | 13 Nov 2025

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that… read more.

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program

Written by Charlie King | 31 Oct 2025

Nearly one-third of people with type 2 diabetes (T2D) in an Indian cohort achieved remission through an intensive lifestyle intervention program, according to a new study publishing October… read more.

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Written by Charlie King | 7 Oct 2025

New research being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept), reveals type 2 diabetes (T2D) as… read more.

EASD launches its first ever clinical practice guideline – the world’s first to focus on diabetes distress

Written by Charlie King | 22 Sep 2025

The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard Operating Procedures… read more.

Cannabis use appears to increase risk of type 2 diabetes

Written by Bruce Sylvester | 18 Sep 2025

A large retrospective study suggests that cannabis use could quadruple the risk of developing type 2 diabetes. The findings were presented on Sept. 15, 2025 at the Annual… read more.

CPAP treatment saves lives of sleep apnea patients with type 2 diabetes

Written by Bruce Sylvester | 9 Sep 2025

Patients with both T2D (type 2 diabetes) and OSA (obstructive sleep apnea) who were treated with CPAP (continuous positive airway pressure) achieved an approximately 26% lower risk of… read more.

Metformin linked to lower risk of dementia and death in obese patients

Written by Bruce Sylvester | 9 Aug 2025

Use of the diabetes drug metformin appears to be linked to reduced risk of dementia and death in obese patients, researchers reported on August 6, 2025 in Diabetes,… read more.

Obesity and type 2 diabetes in teen years can impair bone health

Written by Charlie King | 16 Jul 2025

Obesity and type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in life, according to a study being… read more.

Over decades, a healthy lifestyle outperforms metformin in preventing onset of Type 2 diabetes

Written by Charlie King | 7 Jul 2025

In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was better than a medication called metformin at… read more.

Biomea Fusion to present Icovamenib data highlighting durable T2D Control at ADA 2025

Written by Charlie King | 25 Jun 2025

Biomea Fusion, a clinical-stage diabetes and obesity medicines company, announced the presentation of new preclinical and clinical data for icovamenib, the company’s investigational oral menin inhibitor, at the… read more.

Doctors urge FIFA to end deal with Coca-Cola ahead of Club World Cup

Written by Charlie King | 19 Jun 2025

Football’s governing body FIFA should drop Coca-Cola as sponsors of the 2025 Club World Cup which begins this week, urge doctors in The BMJ today. Dr Chris van Tulleken at… read more.

1 2 3 … 7 Next »

Archive

Subscribe for our mailing list

Follow Us